Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.
Open Access
- 1 June 1996
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 55 (6), 403-404
- https://doi.org/10.1136/ard.55.6.403-b
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Correlation of interleukin‐6 production and disease activity in polymyalgia rheumatica and giant cell arteritisArthritis & Rheumatism, 1993
- RA sex ratios, HLA-DR, and testosterone.Annals Of The Rheumatic Diseases, 1993
- Sex ratios and hormones in HLA related rheumatic diseases.Annals Of The Rheumatic Diseases, 1991
- INTERLEUKIN-6 IN SERUM OF PATIENTS WITH POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITISRheumatology, 1990
- The American College of Rheumatology 1990 criteria for the classification of giant cell arteritisArthritis & Rheumatism, 1990
- Stopping steroids in polymyalgia rheumatica and giant cell arteritis.BMJ, 1990
- Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.Annals Of The Rheumatic Diseases, 1989
- Serum c‐reactive protein in polymyalgia rheumatica. A prospective serial studyArthritis & Rheumatism, 1985
- The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.Annals Of The Rheumatic Diseases, 1983
- An evaluation of criteria for polymyalgia rheumatica.Annals Of The Rheumatic Diseases, 1979